Elanco Animal Health (ELAN) executive compensation, 2026 proxy

Jeffrey Simmons, President and CEO, was paid $14.9M in 2025, up 1% from $14.8M the year before. The CEO-to-median-employee pay ratio was 181:1, on median employee pay of $82,675.

Filed
April 8, 2026
Pay year
2025
Named executives
6
CEO total pay
$14.9M+1% vs prior year
CEO to median employee
181:1median $82,675
CEO pay in equity
80%$12M in awards
Prior say-on-pay support
54%of votes cast
CEO Stock Awards
$9,000,000Grant date fair value
CEO Option Awards
$3,000,004Grant date fair value
Annual Bonus Payout
109%Percentage of target
Performance Share Payout
106%For 2024-2025 period

How Simmons was paid

$14.9M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary8%Stock awards60%Option awards20%Non-equity incentive11%All other compensation0%

Named executive officers

ExecutiveTotal
Jeffrey SimmonsPresident and CEO$14,925,756
Robert VanHimbergenExecutive Vice President and Chief Financial Officer$4,661,304
Ellen de BrabanderExecutive Vice President, Innovation and Regulatory$3,911,229
Ramiro CabralExecutive Vice President, President International$3,243,767
Timothy BettingtonExecutive Vice President, Center for Strategic Growth$2,583,505
Todd YoungFormer Executive Vice President and Chief Financial Officer$4,754,889

What changed and why

  • $14.9MCEO total compensation increased slightly to $14,925,756 in 2025 from $14,833,704 in 2024.
  • 109%Annual cash incentives for executives paid out at 109% of target based on performance.
  • 106%Performance share awards for the 2024-2025 period were earned at 106% of target.
  • 25%For 2026, incentive programs were modified to incorporate a relative total shareholder return metric weighted at 25%.
  • Sales growth modifiers were added to 2026 annual cash incentives to adjust payouts up or down.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.